Intracranial chordoid glioma: A clinical, radiological and pathological study of 14 cases

医学 尿崩症 第三脑室 放射性武器 垂体机能减退 外科 病态的 颅咽管瘤 脑积水 终板 放射科 儿科 内科学 中枢神经系统
作者
Guobin Zhang,Hua-Wei Huang,Hao-Yi Li,Xiaokang Zhang,Yonggang Wang,Song Lin
出处
期刊:Journal of Clinical Neuroscience [Elsevier BV]
卷期号:80: 267-273 被引量:7
标识
DOI:10.1016/j.jocn.2020.09.019
摘要

Background Chordoid gliomas (CGs) are rare neuroepithelial tumors, which commonly arise from the anterior part of the third ventricle. Most studies on CGs included only one or two cases. To better understand the disease, we report 14 patients with pathologically confirmed CGs. Method The clinical characteristics, including radiological and histological examination, operative records, and prognoses were analyzed and reviewed. Result The case series included six male and eight female patients with an average age of 44.4 years. The most common preoperative symptom was headache (64.3%) and visual deterioration (57.1%). Radiological results showed that the third ventricle (12/14) was the most common site of the brain involved, and the lesions presented with solid (n = 9, 64.3%) or cystic-solid (n = 5, 35.7%) appearance. All patients were misdiagnosed as non-CG tumors. The operation approach was mainly determined by tumor location, thus trans-callosal approach (9/14) and trans-laminar terminalis approach were commonly used. Gross total resection (GTR) was achieved in all cases and none of them received any adjuvant therapy postoperatively. The most frequent postoperative complications were diabetes insipidus, electrolyte disturbance, hypopituitarism, cognitive dysfunction, and obstructive hydrocephalus. During an average follow-up period of 40.1 months, 2 cases (14.3%) were died of refractory hypopituitarism and pulmonary embolism, respectively. The preoperative symptoms and postoperative complications were all significantly improved in other 12 patients, and MRI showed no tumor recurrence. Conclusion According to our experience, we recommend GTR as the primary goal, which is associated with improved rates of tumor control and without increasing rates of postoperative complications.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
老迟到的友菱完成签到,获得积分10
刚刚
科研混子完成签到 ,获得积分10
刚刚
缥缈八宝粥完成签到,获得积分10
2秒前
何禾完成签到,获得积分10
3秒前
蓝橙完成签到,获得积分10
3秒前
wan完成签到,获得积分10
4秒前
能干世倌完成签到,获得积分10
4秒前
April完成签到 ,获得积分10
5秒前
郑鹏飞完成签到,获得积分10
6秒前
wangxuezhibuct完成签到,获得积分10
6秒前
MoiMoi完成签到,获得积分20
6秒前
个性青寒完成签到,获得积分10
8秒前
科研通AI6.4应助瘦洋洋采纳,获得10
9秒前
少艾完成签到 ,获得积分10
9秒前
喜悦蚂蚁完成签到,获得积分10
9秒前
Lucas应助liu采纳,获得10
9秒前
生动觅柔完成签到,获得积分10
10秒前
11秒前
kejinyang完成签到,获得积分10
11秒前
希希完成签到 ,获得积分10
12秒前
碳烤小肥肠完成签到,获得积分10
12秒前
艾因兹怀斯完成签到,获得积分10
12秒前
13秒前
13秒前
木子也是李完成签到,获得积分10
13秒前
烟花应助ayan1203采纳,获得10
14秒前
DKJ应助ajs采纳,获得10
14秒前
Zllu完成签到,获得积分10
14秒前
just完成签到,获得积分10
15秒前
tsai完成签到,获得积分10
15秒前
汉堡包应助waka采纳,获得10
15秒前
朴实涵山完成签到 ,获得积分10
16秒前
瑞一杯小黄油拿铁完成签到,获得积分10
16秒前
现代的南风完成签到 ,获得积分10
16秒前
16秒前
romeskq完成签到,获得积分10
16秒前
求是鹰完成签到,获得积分10
17秒前
17秒前
陈怀祚发布了新的文献求助10
17秒前
贯云完成签到,获得积分10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
University Physics for the Life Sciences 500
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6951248
求助须知:如何正确求助?哪些是违规求助? 8635501
关于积分的说明 18310063
捐赠科研通 6393428
什么是DOI,文献DOI怎么找? 3082001
关于科研通互助平台的介绍 2127081
邀请新用户注册赠送积分活动 2058885